tiprankstipranks
RVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
PremiumThe FlyRVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
8M ago
Cantor biotech/biopharma analysts to hold analyst/industry conference call
PremiumThe Fly
Cantor biotech/biopharma analysts to hold analyst/industry conference call
8M ago
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
PremiumPress Releases
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
8M ago
RVLP Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsRVLP Upcoming Earnings Report: What to Expect?
8M ago
Cantor biotech/biopharma analysts to hold analyst/industry conference call
PremiumThe Fly
Cantor biotech/biopharma analysts to hold analyst/industry conference call
9M ago
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
PremiumPress Releases
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
9M ago
RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
PremiumPress ReleasesRVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
11M ago
RVLP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RVLP Earnings this Week: How Will it Perform?
12M ago
RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
PremiumPress Releases
RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100